Advertisement

ApoCell, Inc. Company Profile

17:18 EDT 23rd May 2013 | BioPortfolio

Based in Houston, Texas, ApoCell (www.apocell.com) is a privately-held specialty clinical research company. Founded in 2004, the firm is a leader in molecular biomarker detection and analysis and leverages its expertise in the areas of oncology, diabetes, molecular diagnostics and drug development to measure biomarker signatures in clinical trial subjects. The company’s proprietary methods provide early proof of mechanism of action and monitor the effectiveness of various types of drugs by measuring biomarker expression patterns in biopsies, blood and rare cell types. The company’s facilities are CLIA-certified and compliant with applicable FDA regulations. Since inception, the company has participated in over 120 Phase I, II, and III clinical cancer drug trials for more than 80 sponsor clients worldwide.


News Articles [ 6 Associated News Articles listed on BioPortfolio]

ApoCell: Phase I/II started

ApoCell regulatory update

ApoCell Announces Delivery of First Prototypes of ApoStream™ Circulating Tumor Cell (CTC) Isolation Technology to National Cancer Institute

HOUSTON, May 15, 2013 /PRNewswire/ -- ApoCell, Inc. announced that the first prototypes of its ApoStream™ circulating tumor cell (CTC) isolation system have been delivered to select investi...

ApoCell to present CTC recovery technology study abstracts

ApoCell will present the study abstracts of its circulating tumor cells (CTC) recovery technology at the Molecular Targets and Cancer Therapeutics Conference, which will be held in Dublin, Ireland fro...

Hadasit Bio-Holdings Flagship Portfolio Company Enlivex Awarded Orphan Drug Status for ApoCell Treatment by the FDA

JERUSALEM, April 4, 2013 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed and own...

Enlivex Therapeutics Announces Positive Results in Completion of Clinical Trial for the Treatment of Bone Marrow Transplant Recipients

JERUSALEM, Oct. 24, 2012 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed and own...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [ 2 Associated Companies listed on BioPortfolio]

ApoCell, Inc

ApoCell, Inc. is a biomarker discovery and development company dedicated to accelerating drug development and predicting patient response to improve the quality of treatment decisions for patients wit...

ApoCell, Inc.

Based in Houston, Texas, ApoCell (www.apocell.com) is a privately-held specialty clinical research company. Founded in 2004, the firm is a leader in molecular biomarker detection...

More Information about "ApoCell, Inc." on BioPortfolio

We have published hundreds of ApoCell, Inc. news stories on BioPortfolio along with dozens of ApoCell, Inc. Clinical Trials and PubMed Articles about ApoCell, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ApoCell, Inc. Companies in our database. You can also find out about relevant ApoCell, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement